one thing that I keep thinking about. Cyrus' comm
Post# of 148188
Clearly something leads him to have the confidence to stake his reputation (what he is effectively doing) by making this comment to shareholders. Given that we haven't had big trials with a large enough data set in either of these indications - what has he seen? Has he seen a certain subset of the data - or seen an analysis that suggests the small data sets will prove out to crush it in a larger trial?
Really curious about this.